Throughout the trading week on Stockpickr Answers, investing professionals answer questions posed by members of the Stockpickr community.

The Street.com Ratings Financial Analyst Richard Widows answered questions on Monday.

Recently on TheStreet.com TV, Widows has said that homebuilders such as KB Home ( KBH) have yet to recover, that Chevron ( CVX) and Exxon ( XOM) might be the best plays on the falling price of crude oil and that Chinese tech stocks NetEase ( NTES) and Shanda ( SNDA) have outperformed their benchmarks.

Here are some questions and comments from the Stockpickr community that Widows responded to on Monday.

  • I subscribe to the Taipan Daily, which said to buy Mahanagar Telephone (MTE) before March 31 because of the 3G technology boom in India. What do you think?
    Click here for Widows' response.

  • Buying Direxion Financial Bull 3x Shares (FAS).
    Click here for Widows' response.

  • Whats up with Bristol-Myers (BMY) today?
    Click here for Widows' response.

  • My employer changed its 401(k) offerings, which now include some target funds. Is this type of fund any good?
    Click here for Widows' response.

  • So ProShares Ulta Short 20-Plus Treasury (TBT) vs. iShares 20-Plus Year Treasury (TLT). Is it too hard to pick a side right now? How long do you think it'll be before we have more clarity on the direction treasuries are headed?
    Click here for Widows' response.

  • Is Delphi (DFG) good stock to invest in?
    Click here for Widows' response.

  • Who's on Stockpickr Answers? Dan Fitzpatrick will be on Stockpickr Answers on March 31 to respond to investing and trading questions posed by members of the Stockpickr community. Not a member? Join the Stockpickr community today -- free.
    Stockpickr is a wholly owned subsidiary of TheStreet.com.

    If you liked this article you might like

    Bristol-Myers Squibb Stock Still a Beast?

    There Are Good Opportunities in Stock Picking

    Halozyme Jumps on Immuno-Oncology Deal with Bristol-Myers

    Achillion Shares Are Plunging on Termination of Hepatitis C Pact